Similar articles

• The complications of promiscuity: endocannabinoid action and metabolism.

  Alexander SP, Kendall DA. Alexander SP, et al. Br J Pharmacol. 2007 Nov;152(5):602-23. doi: 10.1038/sj.bjp.0707456. Epub 2007 Sep 17. Br J Pharmacol. 2007. PMID: 17876303 Free PMC article. Review.
• Novel natural and synthetic ligands of the endocannabinoid system.

  Hanus LO, Mechoulam R. Hanus LO, et al. Curr Med Chem. 2010;17(14):1341-59. doi: 10.2174/092986710790980096. Curr Med Chem. 2010. PMID: 20166928 Review.
• Endocannabinoid-binding receptors: old friends and new comers.

  Maccarrone M. Maccarrone M. Curr Med Chem. 2010;17(14):1339-40. doi: 10.2174/092986710790980032. Curr Med Chem. 2010. PMID: 20441559 No abstract available.
• In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.

  Giuffrida A, McMahon LR. Giuffrida A, et al. Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):90-103. doi: 10.1016/j.prostaglandins.2009.05.004. Epub 2009 Jun 10. Prostaglandins Other Lipid Mediat. 2010. PMID: 19523530 Free PMC article. Review.
• The Endocannabinoid System and its Modulation by Phytocannabinoids.

  Di Marzo V, Piscitelli F. Di Marzo V, et al. Neurotherapeutics. 2015 Oct;12(4):692-8. doi: 10.1007/s13311-015-0374-6. Neurotherapeutics. 2015. PMID: 26271952 Free PMC article. Review.